"We remain concerned that your... adverse drug experience reporting system has not been fully validated, and may have resulted in inaccurate assessment and untimely submission of 15-day alerts," FDA said (as quoted by Reuters). Any details about the adverse drug experience reporting system in use would be appreciated.
